These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2527155)

  • 61. Enoximone improves selection of candidates for urgent cardiac transplantation.
    Loisance D; Benvenuti C; Dubois Randé JL; Deleuze P; Castaigne A; Cachera JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S23-7. PubMed ID: 2145234
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
    Zipperle G; Butzer F; Dieterich HA; Heinrich F
    Am J Cardiol; 1987 Aug; 60(5):72C-74C. PubMed ID: 2956873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
    Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M
    Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

  • 65. Enoximone treatment of impaired myocardial function during cardiac surgery: combined effects with epinephrine.
    Boldt J; Kling D; Moosdorf R; Hempelmann G
    J Cardiothorac Anesth; 1990 Aug; 4(4):462-8. PubMed ID: 2151889
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
    Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience.
    Treese N; Erbel R; Pilcher J; Choraria S; Rhein S; Dieterich HA; Meyer J
    Am J Cardiol; 1987 Aug; 60(5):85C-90C. PubMed ID: 2956876
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
    Kereiakes DJ; Viquerat C; Lanzer P; Botvinick EH; Spangenberg R; Buckingham M; Parmley WW; Chatterjee K
    Am Heart J; 1984 Nov; 108(5):1278-84. PubMed ID: 6238512
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.
    Franciosa JA; Silverstein SR
    Clin Pharmacol Ther; 1982 Jul; 32(1):62-9. PubMed ID: 7083731
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Holubarsch C; Pieske B; Hasenfuss G; Just H
    Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patterns of response to intravenous enoximone.
    World MJ
    J R Army Med Corps; 1991 Feb; 137(1):39-43. PubMed ID: 1827156
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of oral long-term enoximone therapy on the arrhythmia profile in chronic heart failure].
    Treese N; Rhein S; Werneyer A; Erbel R; von Olshausen K; Pop T; Meyer J
    Z Kardiol; 1988 Oct; 77(10):653-9. PubMed ID: 2467449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
    Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
    Amin DK; Shah PK; Hulse S; Shellock FG; Swan HJ
    Am Heart J; 1984 Nov; 108(5):1285-92. PubMed ID: 6238513
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nitroprusside-sparing effects of enoximone.
    Chaudhri S; Kenny GN
    Cardiology; 1990; 77 Suppl 3():46-50; discussion 62-7. PubMed ID: 2148280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
    Stemple DR; Kleiman JH; Harrison DC
    Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Tolerance of enoximone in patients with heart failure].
    Gilfrich HJ; Dieterich HA
    Z Kardiol; 1991; 80 Suppl 4():93-7. PubMed ID: 1833904
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential hemodynamic effects of oral enoximone in severe congestive heart failure.
    Murali S; Uretsky BF; Betschart AR; Tokarczyk TR; Kolesar JA; Reddy PS
    Am J Cardiol; 1990 Feb; 65(7):515-9. PubMed ID: 2137668
    [No Abstract]   [Full Text] [Related]  

  • 80. Cardiovascular effects of sulmazol administered intravenously to patients with severe heart failure.
    Hagemeijer F; Segers A; Schelling A
    Eur Heart J; 1984 Feb; 5(2):158-67. PubMed ID: 6723686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.